-

12:21:08 PM

STAA Stock News

STAA - Staar Surgical Co.

05/04/22 4:01 PM

Nasdaq : STAA

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 1, 2022. Record Net Sales of $63.2 Million Up 25% from the Prior Year Quarter ICL Sales of $58.7 Million Up 26% from the Prior Year Quarter Record ICL Units Up...

RHEA-AI

very positive

04/20/22 7:00 AM

Nasdaq : STAA

conferences

STAAR Surgical to Report First Quarter Results on May 4, 2022

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 1, 2022 on Wednesday, May 4, 2022 after the market close. STAAR will host a conference call and webcast on Wednesday, May 4 at 4:30 p.m....

RHEA-AI

neutral

04/06/22 7:00 AM

Nasdaq : STAA

STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first implants of the EVO Visian ® Implantable Collamer ® lens in the U.S. The Company also announced today its program of meetings and presentations during the American Society of Cataract and...

RHEA-AI

neutral

03/28/22 3:01 AM

Nasdaq : STAA

fda approval

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration has granted approval of the EVO/EVO+ Visian ® Implantable Collamer ® Lens for the correction of myopia and myopia with astigmatism. Myopia, which is also known as...

RHEA-AI

neutral

02/23/22 4:01 PM

Nasdaq : STAA

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended December 31, 2021. Net Sales of $59.0 Million Up 28% from the Prior Year Quarter ICL Sales of $53.0 Million Up 33% from the Prior Year Quarter ICL...

RHEA-AI

neutral

02/09/22 7:00 AM

Nasdaq : STAA

conferencesearnings

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2021 on Wednesday, February 23, 2022 after the market close. STAAR will host a conference call and webcast on...

RHEA-AI

neutral

01/10/22 7:00 AM

Nasdaq : STAA

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended December 31, 2021. GAAP earnings per share is expected to be approximately $0.10 for the fourth quarter and approximately $0.50 for the...

RHEA-AI

neutral

11/03/21 4:01 PM

Nasdaq : STAA

STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 1, 2021. Quarterly Net Sales of $58.4 Million Up 24% from the Prior Year Quarter Quarterly ICL Sales of $54.2 Million Up 31% from the Prior Year Quarter...

RHEA-AI

positive

10/20/21 7:00 AM

Nasdaq : STAA

conferences

STAAR Surgical to Report Third Quarter Results on November 3, 2021

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended October 1, 2021 on Wednesday, November 3, 2021 after the market close. STAAR will host a conference call and webcast on Wednesday, November 3...

RHEA-AI

neutral

08/04/21 4:01 PM

Nasdaq : STAA

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 2, 2021.Second Quarter 2021 OverviewRecord Quarterly Net Sales of $62.4

RHEA-AI

neutral

STAA Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.staar.com
CeoCaren Mason
Security nameStaar Surgical Co.
Issue typecs
SectorManufacturing
Sic code3851
Employees575
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address25651 Atlantic Ocean Drive
StateCalifornia
CityLake Forest
Zip92630
CountryUS
Phone16263037902

About Staar Surgical Co.

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.